[Familiar and new aspects of Epstein-Barr virus infection].
The Epstein-Barr virus (EBV) persists after primoinfection in the human host. Over 90% of the adult population carries EBV, which is mainly acquired during childhood or adolescence. The full-blown clinical picture is infectious mononucleosis. Complications are rare but manifold. Symptomatic treatment is sufficient in most instances. Tumors associated with EBV represent a problem of medical relevance especially in the immunocompromised.